ESPERITE N.V. (ESP) SELLS ITS STAKE IN CRYOSAVE SOUTH AFRICA TO GO LIFE HEALTHCARE (GLI).
02 juil. 2018 01h17 HE
|
Esperite N.V.
CryoSave in its joint venture with Ecsponent (ECS) at equal participation have sold 100% of their stake for ZAR 50,000,000 (Fifty Million South African Rand). As a leading stem cells bank,...
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 20th tranche of investment today
28 juin 2018 01h17 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 28 June 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 20th Tranche of EUR 400,000 is issued as a private placement of 40...
Esperite N.V. secures external financing of up to EUR 5 million to support its commercial activity and development of innovative technologies
19 juin 2018 01h17 HE
|
Esperite N.V.
Total investment can reach EUR 7.25 million upon exercise of share subscription warrants Amsterdam, The Netherlands - 19 June 2018 Transaction highlights Potential financing of up to EUR 5...
ESPERITE (ESP) further delays publication of Annual Report 2017.
18 juin 2018 16h24 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 18 June 2018 Esperite regrets to announce that due remaining technical issues as reported before and despite the constant efforts provided by the different teams...
European Select Growth Opportunities Fund subscribes to the 19th tranche of its investment today and has agreed to provide up to EUR 7.25 million in additional funding
12 juin 2018 01h17 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 12 June 2018 Esperite N.V. (Euronext: ESP, "Esperite" or the "Group") announces today the issuance to European Select Growth Opportunities Fund (the "Investor" or...
ESPERITE NV (ESP) LAUNCHS NEW AGAATA Dx, DIAGNOSTIC SYSTEM WITH MACHINE LEARNING CAPABILITIES FOR GENETIC CLINICAL LABORATORIES.
06 juin 2018 02h26 HE
|
Esperite N.V.
AGAATA delivers clinical reports in the fields of Reproductive Health, Oncology and Inherited Diseases. Amsterdam, The Netherlands -6th June 2018 AGAATA innovates a fully integrated and certified...
ESPERITE (ESP) expects publication of Annual Report 2017 before 18 June 2018
05 juin 2018 01h17 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 05 June 2018 Esperite regrets to announce that due to the technical issues as reported on 30 April and despite the constant efforts provided by the different teams...
Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn's disease.
17 mai 2018 08h32 HE
|
Esperite N.V.
Amsterdam, The Netherlands -17th May 2018 Esperite's The Cell Factory has signed today the agreement with PHARM, the Italian CRO company which is preparing for the first-in-man clinical trials...
ESPERITE (ESP) : L1 Capital subscribes to the 18th tranche of investment today
17 mai 2018 01h17 HE
|
Esperite N.V.
Amsterdam, The Netherlands - 17 May 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the 18th Tranche of EUR 400,000 is issued as a private placement of 40...
ESPERITE NV (ESP) WITH CRYOSAVE TAKES OVER FULL CONTROL OF BUSINESS IN SOUTH AFRICA AND INTEND TO DISTRIBUTE ADVANCED SERVICES TO THE GROWING AFRICAN POPULATION
16 mai 2018 03h31 HE
|
Esperite N.V.
Amsterdam, the Netherlands - 16 May 2018 Esperite NV, The Regenerative and predictive medicine company has acquired control of its long-term South African joint venture CryoSave South Africa Ltd....